Objective—Therapeutic angiogenesis using autologous stem/progenitor cells represents a
novel strategy for severe ischemic diseases. Recent reports indicated that adipose tissues …

Therapeutic angiogenesis has emerged as a promising therapy to treat patients with
ischemic diseases. Transplantation of bone marrow cells (BMCs) is reported to augment …

Abstract Background/Aim: It has been reported that adipose tissue contain progenitor cells
with angiogenic potential and that therapy based on adipose tissuederived progenitor cells …

Transplantation of adipose-derived regenerative cell (ADRC) enhances ischemia-induced
angiogenesis, but the underlying mechanism remains unknown. Here, we compared the …

Background—Adipose tissue development and remodeling are closely associated with the
growth of vascular network. We hypothesized that adipose tissue may contain progenitor …

Objective—The delivery of autologous progenitor cells into ischemic tissue of patients is
emerging as a novel therapeutic option. Here, we report the potential impact of cultured …

Therapeutic angiogenesis is an important means to salvage tissues against severe ischemic
diseases in patients with no option for other vascular intervention. A number of recent …

We examined the protective effect of unsorted human adipose tissue-derived stem cells
(hADSCs) with a short-term culture in endothelial differentiation medium on tissue repair …

Ischemic diseases, the leading cause of disability and death, are caused by the stenosis or
obstruction of arterioles/capillaries that is not compensated for by vessel dilatation or …

Stem cells offer significant therapeutic promise for the treatment of ischemic disease.
However, stem cells transplanted into ischemic tissue exhibit limited therapeutic efficacy due …